The development of the nebulizers market is anticipated to be driven by the development of sophisticated nebulizers that use aerosol medicine delivery technology with little drug waste. Patients actively participate in managing their illnesses by selecting tools that allow them to diagnose and treat themselves in the comfort of their own homes. This change in patient preferences will support the projected expansion of the worldwide nebulizer market in the near future. Another important aspect is the increase in respiratory illnesses. According to the World Health Organisation (WHO), there were approximately 15.7 million cases of chronic obstructive pulmonary disease (COPD) in the United States in 2016, a significant 6.4% rise from 2015.
Nebulizers are also used for a number of diagnostic tests, the most important one being the diagnosis of lung and bronchial activity. This has also contributed to the increase in the market's demand for nebulizers from experts for usage in clinical settings and for tracking a variety of related respiratory ailments.
The size of the Global Nebulizer Market was evaluated at USD 1.07 billion in 2022, and it is projected to rise at a CAGR of 5.9% from 2023 to 2030.
Major Players in the Nebulizers Industry:
1. GE Healthcare Ltd: A provider of ground-breaking medical technologies and services is GE Healthcare. It focuses on biopharmaceutical manufacturing technologies, computerised data management, performance enhancement, medical equipment, and performance services. It also specialises in medical imaging, information technologies, medical diagnostics, patient monitoring systems, drug development, and performance services. Chicago, Illinois serves as the company's headquarters. It was established in 1892. It pursues an aggressive acquisition strategy and concentrates on forming alliances with healthcare industry titans in an effort to strengthen the business' position in developing markets and increase the scope of its life sciences offerings.
2. Agilent Technologies: Agilent, which was first separated from Hewlett-Packard in 1999, has grown into a major player in the life sciences and diagnostics industries. With its three operating segments life science and applied tools, cross lab (containing of consumables and services connected to its life science and applied tools), and diagnostics and genomics Agilent's measuring solutions currently serve a wide range of customers. Created in 1999. Headquarters are in Santa Clara, California, USA.
3. Philips Healthcare: Devices made with liquid resin are produced. The business manufactures plastic thermosetting polymers, synthetic resin, and plastic casting, among other things. Located in the Netherlands.
4. CareFusion Corporation: The Company offers a range of medical technology products that aid healthcare organisations in improving infection control, medication management, medical supply management, and respiratory care. These products include automated dispensing and patient identification systems, respiratory ventilators, as well as surgical instruments needed for infection prevention, neurological monitoring, and diagnosis. Created in 2009. Based in San Diego, California, in the United States.
5. Covidien plc: supplier of medical supplies. In the US, the business runs a network of 37 Mallinckrodt radiopharmacies. Orlando, Florida, serves as the corporate headquarters.
6. Omron Healthcare Co.: Established in 1933. Manufacturers of medical and healthcare monitoring equipment designed to keep an eye on a patient's vital signs. Home blood pressure monitors, nebulizers, fitness devices including pedometers and heart rate monitors, TENS Units, and scales are some of the company's medical record products that allow patients and doctors to monitor crucial health indicators. United States headquarters in Lake Forest. The issued and outstanding common stock of JMDC will be purchased by OMRON from Noritsu Koki Co., Ltd.
*Definition: A nebulizer is a device that turns the liquid medicine into a mist which is then inhaled through a mouthpiece or a mask.
